SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan. - Wikidata - awgldk - TriplyDB

SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan.

SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan.

http://www.wikidata.org/entity/Q46176230

about

Genetics and visceral leishmaniasis: of mice and man The human solute carrier family 11 member 1 protein (SLC11A1): linking infections, autoimmunity and cancer?Leishmaniasis in Uganda: historical account and a review of the literature Postgenomic research on leishmaniasis: a critical self-appraisal Genetic admixture in Brazilians exposed to infection with Leishmania chagasi.Genes at human chromosome 5q31.1 regulate delayed-type hypersensitivity responses associated with Leishmania chagasi infection No evidence for association between SLC11A1 and visceral leishmaniasis in India.Y chromosome lineage- and village-specific genes on chromosomes 1p22 and 6q27 control visceral leishmaniasis in Sudan.CXCR1 and SLC11A1 polymorphisms affect susceptibility to cutaneous leishmaniasis in Brazil: a case-control and family-based study.Classification and regression tree and spatial analyses reveal geographic heterogeneity in genome wide linkage study of Indian visceral leishmaniasis.Fine mapping of Leishmania major susceptibility Locus lmr2 and evidence of a role for Fli1 in disease and wound healing.Immune regulation during chronic visceral leishmaniasis.Evidence of association with type 1 diabetes in the SLC11A1 gene region.Association of SLC11A1 with tuberculosis and interactions with NOS2A and TLR2 in African-Americans and Caucasians.RNA-binding protein HuR is required for stabilization of SLC11A1 mRNA and SLC11A1 protein expression Genetic control of canine leishmaniasis: genome-wide association study and genomic selection analysis.Balancing immunity and pathology in visceral leishmaniasis.Immunobiology of visceral leishmaniasis.Transmembrane molecules for phylogenetic analyses of pathogenic protists: Leishmania-specific informative sites in hydrophilic loops of trans- endoplasmic reticulum N-acetylglucosamine-1-phosphate transferase.The immunopathology of experimental visceral leishmaniasis.Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis.Risk factors of visceral leishmaniasis in East Africa: a case-control study in Pokot territory of Kenya and Uganda.Slc11a1 (formerly Nramp1) and susceptibility to canine visceral leishmaniasis.Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasis NRAMP1 Polymorphisms like Susceptibility Marker in Mexican Focus of Cutaneous Leishmaniasis Cutaneous leishmaniasis: disease susceptibility and pharmacogenetic implications.SLC11A1 polymorphisms and host susceptibility to cutaneous leishmaniasis in Pakistan.Interdependence of hypoxic and innate immune responses Iron metabolism in trypanosomatids, and its crucial role in infection.Asymptomatic Leishmania infection: a new challenge for Leishmania control.Genetic risk factors for human susceptibility to infections of relevance in dermatology.Vaccine Development Against Leishmania donovani.Genetics of leprosy reactions: an overview.Post kala-azar dermal leishmaniasis: an unresolved mystery Host genetic factors in American cutaneous leishmaniasis: a critical appraisal of studies conducted in an endemic area of Brazil.Lipoprotein lipase and PPAR alpha gene polymorphisms, increased very-low-density lipoprotein levels, and decreased high-density lipoprotein levels as risk markers for the development of visceral leishmaniasis by Leishmania infantum.Comprehensive candidate gene analysis for symptomatic or asymptomatic outcomes of Leishmania infantum infection in Brazil.Exome Sequencing Identifies Two Variants of the Alkylglycerol Monooxygenase Gene as a Cause of Relapses in Visceral Leishmaniasis in Children, in Sudan.SLC11A1 polymorphisms in inflammatory bowel disease and Mycobacterium avium subspecies paratuberculosis status.M. paratuberculosis Heat Shock Protein 65 and Human Diseases: Bridging Infection and Autoimmunity

P2860

Q24612701-1E0573DB-760F-42BE-BDD6-B7B0CD04524B Q24675052-F286DEBD-4626-4A18-9186-7F1780B0E582 Q26830527-EC172107-FBCC-4FA9-B774-3D15C0C46F09 Q28748982-E9E0DE55-65FC-456E-8859-04F28A8DCA76 Q30438885-3B047BE5-E975-4C08-98AA-66FA35DDB704 Q30441556-D473DB9B-322E-46F3-A1EB-2B9888014E82 Q31012721-5EBEEFAB-4800-4693-AB64-E556385E6AC1 Q33284534-AD82ADF0-AD5D-421E-8499-978F154AC778 Q33525373-81640FE9-84C2-4A73-9876-A8EDC5AAB8D9 Q33786681-B45F1BEB-10BA-47F2-BAB1-C193EB94E64A Q33877106-EF974552-7B4D-412C-B87D-0E271E9C0B6A Q33881718-9D10EABC-998A-4070-897D-E4CD27A69588 Q33882873-3D3FD528-DA86-48D7-B24B-60DE4BF17C50 Q33986128-73175D53-D114-4135-B9AA-C4CFFD2E74C4 Q34042788-7B159392-1EBF-49AF-98BA-BA5E22FA9147 Q34256392-880A6E0A-DCDB-42EA-A12B-45A8E71A0D19 Q34587432-37902863-2E26-4C85-92B2-652FC8733952 Q34641680-F210F0FA-A0E4-43D0-AA13-3E9F7151ACF3 Q35636496-08776C8F-AA5E-4469-88E1-37B10528CE12 Q35884243-718129E5-9DB7-40AE-AE47-C38F46ADF580 Q36875283-B9CFE8AB-2E9E-4ED3-8262-CE0200FC3E2D Q37088734-CCB60384-FB67-492D-AEE9-7F9CC5586EC8 Q37184069-14031B3B-FA8B-4EE2-8609-60E1F1457AB5 Q37251607-9C1A222D-FF54-45BA-A0EE-813D9A014623 Q37382666-BEA40E93-4DB7-4074-B94C-343AD83C2AB6 Q37416125-40E3393F-87A9-4223-AB23-9D03764D1ACB Q37569433-3C481318-12C6-4665-B6A5-72E2EC25E785 Q37586121-E9B2D55A-570F-4E33-B0BC-9D2C40964178 Q37691483-87BAF96A-CEC4-45FF-A7EB-5782C2B91624 Q37726064-D01C95B1-3B3A-4EFF-9820-E6C63F51FC57 Q37944170-1B105B1D-2DA5-440C-B16D-D93BFEB7F399 Q38012112-02CE2882-D003-4A79-8C3E-A86347EECCC8 Q38071237-39857853-70CA-4D3A-89C4-035E580A3D44 Q38175646-5484913B-75F7-4279-BC77-43A05A85354D Q38215168-6DF302B4-599D-400D-93E9-F4ED92AA9A59 Q38933584-95316630-5CD5-4B5D-9006-E0340C8C491D Q39585356-94C75A3C-04E1-4132-A29E-670DB45ED973 Q40053798-D9AB2A9D-9BE1-48AB-9187-EBC868877FF4 Q41181729-B62F22E3-BC52-4183-B61E-9AF6E54E565F Q42150384-CBE8701B-6DB0-40B9-8CF3-C5D18649008F

P2860

SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan.

http://www.wikidata.org/entity/Q46176230

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan.

@en

type

label

SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan.

@en

prefLabel

SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan.

@en

P1433

Q46176230-312852DA-443D-494D-9D61-C0F04405A5AD

P1476

Q46176230-6869500A-5F33-420B-AFBE-0C17E862C4F8

P2093

Q46176230-098B8E91-18BB-4DB6-B38C-2A005D09805E

Q46176230-0D602051-A832-45F8-9131-2B8E693EF6F5

Q46176230-14039F9F-F746-424C-939E-5E9C1E3F4015

Q46176230-44F80C9F-58BF-4855-BEA2-89AFA1F07304

Q46176230-D7255B25-1412-49AC-A7D7-552A46C9CD97

Q46176230-E6D8A86C-F151-45C5-952C-8094530E7E4B

Q46176230-F2B8C09D-0D96-408E-A5C1-529A1493A841

Q46176230-F5B5030B-F35F-4E2B-8618-29FDCF96D1C2

P2860

Q46176230-02822A18-DB09-4376-B62C-8DE7C4DF287B

Q46176230-0328146B-D4C0-469A-89B3-0A46EDF9C062

Q46176230-0330EE9F-9084-4A65-9AFA-730A7FE9E4F0

Q46176230-0788E74E-C279-4D91-B548-FBAA53EA0665

Q46176230-10EB59FA-1901-474F-9C2E-12AF756E8A90

Q46176230-1310AC85-EA63-4BEF-8697-E334F2A4136F

Q46176230-1D06BBFA-B8E9-4643-864F-299CE70E62A0

Q46176230-3AF192F7-EC05-4410-B545-6D62BD074ACA

Q46176230-46AA4893-94E5-446F-8AE6-6811C3CF0805

Q46176230-48354108-3F87-4644-8594-A772659D97DF

P2888

Q46176230-454E0D5A-8F2C-4F6B-85B1-9B6858F232D4

P304

Q46176230-118742D4-46A8-4445-A881-4616ED50AB09

P31

Q46176230-1614E02E-D295-4D64-A66A-251511C9ABDB

P356

Q46176230-26A9DBAB-8B4B-4EC1-8961-CF251FA6D118

P433

Q46176230-2C43A2D0-D878-4F15-B868-387C35D2A3FD

P478

Q46176230-05ECC789-97AF-44ED-A718-707F06AD9914

P50

Q46176230-797333C3-EF6B-4A92-B062-DC950AB706FE

Q46176230-DAA50E48-0E80-4CCF-A023-ED3BA3D349F0

P577

Q46176230-89CA54CA-2D2F-4EDD-8DCB-9C070F4ADD2E

P5875

Q46176230-D044985E-9E4C-4A48-A514-C6EB1BD81E5F

P698

Q46176230-25BD968E-0174-41C5-ACFD-C86DF2B38410

P921

Q46176230-239E9C90-8C57-4534-8E88-A4DC8275BE9C

Q46176230-4C99889E-1D68-411E-9085-95BE4BDF13CC

P356

SJ.EJHG.5201089

P1433

European Journal of Human Genetics

P1476

SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan

@en

P2093

Ahmed Mohamed El Hassan

http://www.w3.org/2001/XMLSchema#string

Christopher Sean Peacock

http://www.w3.org/2001/XMLSchema#string

Elinor Nancy Miller

http://www.w3.org/2001/XMLSchema#string

Heather Jane Cordell

http://www.w3.org/2001/XMLSchema#string

Hiba Salah Mohamed

http://www.w3.org/2001/XMLSchema#string

Jacqueline Katie White

http://www.w3.org/2001/XMLSchema#string

Jenefer Mary Blackwell

http://www.w3.org/2001/XMLSchema#string

Muntaser Eltayeb Ibrahim

http://www.w3.org/2001/XMLSchema#string

P2860

Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome

Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression

Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg

The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene

Allegro, a new computer program for multipoint linkage analysis

NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control

A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes

Linkage of rheumatoid arthritis to the candidate gene NRAMP1 on 2q35

Understanding the multiple functions of Nramp1.

Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family.

P2888

sj.ejhg.5201089

P304

66-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.EJHG.5201089

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9069156

http://www.w3.org/2001/XMLSchema#string

P698

14523377

http://www.w3.org/2001/XMLSchema#string

P921

visceral leishmaniasis